Certain breast cancer types, like luminal cancer and those in dense breasts, are more likely to be missed by AI in mammography screening.
Key Details
- 1South Korean researchers reviewed breast images from nearly 1,100 women screened between 2014 and 2020.
- 2AI tools were found to miss cancers with features such as luminal subtype, dense breast tissue, and lesions outside the mammary zone.
- 3The study was published in RSNA's journal Radiology.
- 4Experts urge careful assessment of cases at higher risk of AI error.
Why It Matters
Understanding which cancers AI is most likely to miss can help optimize AI integration into breast imaging workflows, ensuring that radiologists remain vigilant in specific high-risk contexts. This research offers guidance to improve both detection and patient outcomes.
Source
Radiology Business
Related News
•Health Imaging
Most FDA-Cleared AI Devices Lack Pre-Approval Safety Data, Study Finds
A new study finds fewer than 30% of FDA-cleared AI medical devices reported key safety or adverse event data before approval.
•Health Imaging
BMI Significantly Impacts AI Accuracy in CT Lung Nodule Detection
New research demonstrates that high BMI negatively impacts both human and AI performance in chest low-dose CT interpretation, highlighting dataset diversity concerns.
•AuntMinnie
AI for Breast Cancer Screening Not Cost-Effective, Study Finds
AI-assisted breast cancer screening showed minor clinical benefits over DBT alone but was not cost-effective at standard willingness-to-pay thresholds.